Myocardial Failure
8
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure
The Usefulness of Myocardial Work IndeX in ExtraCorporeal Membrane Oxygenation Patients
Evaluating the Adherence Improving Self-Management Strategy Intervention in Chronic Heart Failure Patients
Monitoring Drug-induced Myocarditis (CardiTOX)
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants
A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function